Addressing the #1 Cause of Death After a Heart Attack
We’re Reinventing the Standard of Care in Mechanical Circulatory Support
THE PROBLEM
A serious, life-threatening condition - Cardiogenic Shock
Cardiogenic shock has 40%-60% mortality rate
- #1 cause of death after a heart attack
- Key risk for patients with Acute Decompensated Heart Failure
There remains a significant unmet clinical need
Mechanical circulatory support (MCS) is required when the heart is unable to pump sufficient blood & oxygen to the body, resulting in end-organ failure
Significant complication risks with the current standard of care
- Major bleeding
- Sepsis
- Infection
- Vascular injury
- Hemolysis
- Arterial blockages leading to limb ischemia or stroke
OUR SOLUTION
Introducing Percutaneous Synchronized Cardiac Assist (PSCA)
Our implant uses an inflatable balloon to apply ECG-synchronized left ventricular compression, without entering the heart or bloodstream
Enlarge photoHow it works
Highly differentiated technology
This novel implant and its extravascular placement (using a simple, less invasive procedure) is designed to avoid many of the risks and complications of current, temporary MCS devices
Extravascular/extracardiac
Less invasive and avoids hemolysis, stroke
No contrast imaging
Reduces contrast-induced nephropathy
No anticoagulants
Minimizes bleeding
THE OPPORTUNITY
Platform play with multi-billion $ global markets*
$18B
Acute Market | Cardiogenic Shock
$9B
Chronic Market | Heart Failure
Experienced Leadership Team
100+ years of combined experience successfully advancing innovation in leading MedTech companies
Gerardo Noriega
President/CEO
Albert Chin, MD
Chief Innovation Officer
Jim Heslin
IP Counsel
Susan Osborne
VP Regulatory, Clinical and Quality
Bezhad Behrooz
VP R&D and Operations
Ann Benham
Head of Marketing
World-Renowned Clinical Advisory Board
Daniel Burkhoff, MD, Ph.D
Director of Heart Failure, Hemodynamics & MCS Cardiovascular Research Foundation
Prof. Petr Neužil, MD
Chairman, Dept of Cardiology, Na Homolce Hospital, Prague, CZ
Mitchell Krukoff, MD
Director, Cardiovascular Devices Unit, Duke University Medical Center
Kendrick Shunk, MD
Chief Interventional Cardiology UCSF/SFVA
Dan Meyer, MD
Chief of Cardiac Transplantation, Baylor Scott & White Hospital Dallas
William O'Neill, MD
Medical Director of the Center for Structural Heart Disease, Henry Ford Hospital
Henry Hsia, MD
Chief of VT and Electrophysiology at UCSF, FACC, Professor of Medicine
Announcements
PercAssist's PSCA System - Intrapericardial Mechanical Circulatory Support (MCS) System for Cardiogenic Shock Presented at the TCT24
PercAssist, Inc., a medical device company developing innovative technology for extravascular / extracardiac Mechanical Circulatory Support to provide hemodynamic improvements for patients in cardiogenic shock (CS), today announced that new data was presented at two sessions at the Transcatheter Cardiovascular Therapeutics (TCT24) Conference in Washington, DC, Oct. 27-30, 2024.
PercAssist Announces Multiple Patients Treated In the EUREKA Study of PSCA System for Hemodynamic Support in Chronic Heart Failure
PercAssist, Inc. announces additional successful in human use of its percutaneous subxiphoid cardiac assist (PSCA) device to support an acute myocardial infarction patient with decompensated heart failure at NA Homolce Hospital in Prague with hemodynamic stabilization of the patient for a five day period.
PercAssist Announces First Patient Treated in EUREKA Study of PSCA System for Hemodynamic Support in Chronic Heart Failure
PercAssist, Inc. announces the successful first in human use of its percutaneous subxiphoid cardiac assist (PSCA) device to support an acute myocardial infarction patient with decompensated heart failure at NA Homolce Hospital in Prague with hemodynamic stabilization of the patient for a five day period.
Innovative Heart Failure Treatment to be Highlighted at the American College of Cardiology
PercAssist to present cutting-edge heart failure technology at major cardiology annual meeting.
PercAssist one of ten finalists at the ADA 2022 Silicon Valley Leaders Forum HealthTech Showcase
Company's technology showcased at prestigious competition.